CN Patent

CN120504661B — Alkbh8小分子抑制剂及其制备方法和用途

Assigned to Fudan University · Expires 2025-11-07 · 1y expired

What this patent protects

本发明涉及ALKBH8小分子抑制剂及其制备方法和用途。具体地，本发明公开了一种式I所示化合物的ALKBH8小分子抑制剂，本发明还提供了所述化合物的制备方法，并通过实验证明了ALKBH8是一个潜在的衰老抑制剂新靶点，还公开了所述化合物在预防和/或治疗衰老相关疾病方面的用途。 (I)。

USPTO Abstract

本发明涉及ALKBH8小分子抑制剂及其制备方法和用途。具体地，本发明公开了一种式I所示化合物的ALKBH8小分子抑制剂，本发明还提供了所述化合物的制备方法，并通过实验证明了ALKBH8是一个潜在的衰老抑制剂新靶点，还公开了所述化合物在预防和/或治疗衰老相关疾病方面的用途。 (I)。

Drugs covered by this patent

Patent Metadata

Patent number: CN120504661B
Jurisdiction: CN
Classification: —
Expires: 2025-11-07
Drug substance claim: No
Drug product claim: No
Assignee: Fudan University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.